Skip to main content

Table 3 Hematological and non-hematological toxicity (maximum pre patient and type)

From: Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

Toxicity

NCI grade 3/4

 

≤ 75 years

>75 years

Single agent

Combination

Anemia

21 (4 %)

10 (2 %)

22 (4 %)

9 (2 %)

Leukopenia

10 (2 %)

4 (1 %)

1 (0 %)

13 (2 %)

Neutropenia

8 (2 %)

7 (2 %)

2 (0 %)

13 (2 %)

Thrombopenia

12 (2 %)

5 (1 %)

6 (2 %)

11 (2 %)

Nausea

15 (2 %)

9 (2 %)

11 (2 %)

13 (2 %)

Vomiting

8 (2 %)

5 (1 %)

4 (1 %)

9 (2 %)

Diarrhea

24 (4 %)

13 (2 %)

12 (2 %)

26 (4 %)

Mucositis/ stomatitis

4 (1 %)

4 (1 %)

6 (1 %)

3 (1 %)

Bilirubin elevation

16 (3 %)

20 (4 %)

19 (4 %)

27 (5 %)

Neuropathy-motor

13 (2 %)

18 (3 %)

19 (4 %)

14 (3 %)

Hand-foot-syndrome

18 (3 %)

19 (4 %)

21 (4 %)

17 (3 %)

Fever

0 (0 %)

1 (0 %)

1 (0 %)

0 (0 %)

Pain

16 (3 %)

15 (3 %)

13 (2 %)

19 (4 %)

Other

28 (5 %)

19 (3 %)

15 (3 %)

34 (6 %)